Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Influence of COPD systemic environment on the myogenic function of muscle precursor cells in vitro

Fig. 1

Cell proliferation was assessed by BrdU assay. (a) MPCs were grown in the presence of proliferation medium containing 10% human serum obtained from control subjects (hu S CONTROL), stable COPD patients (hu S COPD) and COPD patients with an acute exacerbation (hu S AECOPD). (b) Proliferation of MPCs in the presence of hu S AECOPD serum was assessed before and after methylprednisolone (MP) treatment in the absence or presence of the GCR antagonist Mifepristone (MIF). Results are presented as the mean ± SD (n = 12): **p < 0.01 and ***p < 0.001

Back to article page